Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | NQO1 | P15559 | 1/20 | 0.50 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.42 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.41 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70827 | 0.95 | LTA4H (0.52) | LTA4HNQO1SLC5A1SLC5A2ADRA2A | |
| SCHEMBL9278662 | 0.91 | CALM1 (0.51) | LTA4HNQO1CALM1PTGS2TP53 | |
| SCHEMBL9774077 | 0.86 | ALDH1A1 (0.50) | LTA4HNQO1CA12CA1CA2 | |
| SCHEMBL1683212 | 0.86 | NQO1 (0.65) | LTA4HNQO1TSHRTDP1PTGS2 | |
| SCHEMBL17534181 | 0.85 | LTA4H (0.41) | LTA4HNQO1SLC5A1SLC5A2ADRA2A | |
| SCHEMBL8048694 | 0.84 | LTA4H (0.48) | LTA4HNQO1SLC5A1SLC5A2GPR84 | |
| SCHEMBL13384702 | 0.84 | LTA4H (0.44) | LTA4HNQO1SLC5A1SLC5A2TSHR | |
| SCHEMBL200566 | 0.84 | CHRNB4 (0.49) | LTA4HNQO1SLC5A1SLC5A2ADRA2A | |
| SCHEMBL2395245 | 0.84 | CA12 (0.48) | LTA4HNQO1SLC5A1SLC5A2GPR84 | |
| SCHEMBL3574765 | 0.83 | ACHE (0.54) | LTA4HNQO1SLC5A1SLC5A2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10029992-B2 | Diaminotriazine compounds and their use as herbicides | BASF SE (DE) | 2018-07-24 | — | — | US | claimed |
| EP-3134391-A1 | DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2017-03-01 | — | — | EP | claimed |
| US-20170044114-A1 | Diaminotriazine compounds and their use as herbicides | BASF SE (DE) | 2017-02-16 | — | — | US | claimed |
| CN-106232586-A | Diaminotriazine compounds and their use as herbicides | 巴斯夫欧洲公司 | 2016-12-14 | — | — | CN | claimed |
| WO-2015162166-A1 | DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2015-10-29 | — | — | WO | claimed |
| CN-119504380-A | Liquid stabilizer for nitrate compound and preparation method thereof | 南京理工大学 | 2025-02-25 | — | — | CN | disclosed |
| EP-4153555-B1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP ASSETS BV (NL) | 2024-01-31 | — | — | EP | disclosed |
| CN-112320766-B | Preparation method and application of hollow mesoporous inorganic oxide nanosphere solid alkali | 西南大学 | 2023-10-27 | — | — | CN | disclosed |
| EP-4153555-A1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP Assets B.V. (NL) | 2023-03-29 | — | — | EP | disclosed |
| CN-115667201-A | Photooxidation of phenolic compounds | 帝斯曼知识产权资产管理有限公司 | 2023-01-31 | — | — | CN | disclosed |
| WO-2021234080-A1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2021-11-25 | — | — | WO | disclosed |
| CN-112320766-A | Preparation method and application of hollow mesoporous inorganic oxide nanosphere solid base | 西南大学 | 2021-02-05 | — | — | CN | disclosed |
| US-5075415-A | ADHESIVE COMPOSITION FOR FIBROUS MATERIALS BASED ON PHENOL-AMINOPHENOL-FORMALDEHYDE CONDENSATION PRODUCTS | BRIDGESTONE CORPORATION (JP) | 1991-12-24 | — | — | US | disclosed |
| CN-1040597-A | Be used for ingredient of solid catalyst of polymerization of olefins and preparation method thereof | SHELL INT RESEARCH (NL) | 1990-03-21 | — | — | CN | disclosed |
| EP-0298704-A2 | Adhesive composition for fibrous materials and process of its preparation | Bridgestone Corporation (JP) | 1989-01-11 | — | — | EP | disclosed |
| EP-0006990-A1 | N,N-bis-halogenomethyl-carbamic acid esters and process for their preparation | BASF Aktiengesellschaft (DE) | 1980-01-23 | — | — | EP | disclosed |
| US-4146647-A | PHENYLAMIDOXIMES, HYPOTENSIVE AGENTS | LABORATOIRE L. LAFON (FR) | 1979-03-27 | — | — | US | disclosed |
| US-4064179-A | CHEMICAL INTERMEDIATES | GENERAL ELECTRIC COMPANY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4060543-A | Manufacture of 5-cyanovaleric acid and its esters | BASF AKTIENGESELLSCHAFT (DT) | 1977-11-29 | — | — | US | disclosed |
| US-3952063-A | Process for the preparation of an organomercaptophenol from sulfur, a phenol, and an activated olefin or an epoxy compound | GENERAL ELECTRIC COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10029992-B2 | Diaminotriazine compounds and their use as herbicides | NR4A3, CBR3, RCOR3 | LTA4H 4276/4885NQO1 549/4885SLC5A1 1866/4885 |
| US-20170044114-A1 | Diaminotriazine compounds and their use as herbicides | NR4A3, CBR3, RCOR3 | LTA4H 4272/4885NQO1 569/4885SLC5A1 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.